NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE:KD).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are […]
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fermi Inc. ("Fermi" or the "Company") (NASDAQ:FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against AMC Entertainment Holdings, Inc. ("AMC" or the "Company") (NYSE:AMC;APE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against PayPal Holdings, Inc. ("PayPal" or the "Company") (NASDAQ:PYPL).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against REGENXBIO Inc. ("Regenxbio" or the "Company") (NASDAQ:RGNX).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Beyond Meat, Inc. ("Beyond Meat" or the "Company") (NASDAQ:BYND) and certain officers.�� The class action, filed in the United States District Court for the Central District of California, and docketed under
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Snowflake Inc. ("Snowflake" or the "Company") (NYSE:SNOW).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / (ACCESS NEWSWIRE)-The law firm of Kirby McInerney LLP continues its investigation on behalf of KDDI Corporation ("KDDI" or the "Company") (OTC:KDDIY) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ:MREO).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail